Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 1/2 1

Status

Completed 11Recruiting 4Terminated 3Not yet recruiting 3Active not recruiting 3Unknown 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Urinary Bladder Neoplasms 7Peritoneal Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Colorectal Neoplasms 3Carcinoma, Transitional Cell 3Appendiceal Neoplasms 3Urologic Neoplasms 2Urogenital Neoplasms 2Stomach Neoplasms 2Recurrence 2Pseudomyxoma Peritonei 2Ovarian Neoplasms 2Neoplasms by Site 2Neoplasms 2Anus Neoplasms 2Uterine Neoplasms 1Urologic Diseases 1Urogenital Diseases 1Urinary Bladder Diseases 1Sarcoma 1Pleural Neoplasms 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Necrosis 1Mediastinal Neoplasms 1Male Urogenital Diseases 1Gastrointestinal Neoplasms 1Female Urogenital Diseases 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 9Docetaxel 5Mitomycin 4erdafitinib 3durvalumab 3Cystoscopy 3disitamab vedotin 2BCG Vaccine 25-aminolevulinic acid hexyl ester 2tremelimumab 1tislelizumab 1monalizumab 1dodecyl maltoside 1chondroitin sulfate, sodium hyaluronate drug combination 1bicalutamide 1Urine Specimen Collection 1Transurethral Resection of Bladder 1Therapeutic Uses 1Surveys and Questionnaires 1Saline Solution 1Patient Discharge 1Paclitaxel 1Nonsteroidal Anti-Androgens 1Monatide (IMS 3015) 1Mitozytrex 1Metformin 1Magnetic Resonance Spectroscopy 1Laser Therapy 1Hyaluronic Acid 1House Calls 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Non-Muscle Invasive Bladder Neoplasms × Mitomycin × Clear all
NCT06919965 2026-05-08

MoonRISe-3

Janssen Research & Development, LLC

Phase 3 Recruiting
220 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT06704191 2026-03-30

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Mayo Clinic

Phase 1/2 Recruiting
40 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06781879 2025-10-03

COBRA-NMIBC

Aarhus University Hospital

Phase 4 Recruiting
272 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT06696794 2025-02-19

Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients

Tongji Hospital

Phase 3 Recruiting
180 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡